Understanding the molecular regulation of immunoglobulin A (IgA) expression is important as it plays an essential role in the first-line defence through mucosal secretions. Using inbred mouse strains, we identified two independent and dominant acting genetic loci that synergistically cause a 40-fold upregulation in serum IgA levels when introduced into the murine strain C57Bl/6J (B6). The first locus on chromosome 12 appears to be mainly responsible for the natural four-fold higher IgA levels in C3HeB/FeJ (C3H) compared to B6 mice. A second independent, chemically induced mutation on chromosome 5 caused a two-fold elevation when transferred from C3H into B6 mice. Both loci in concert effect a 40-fold elevation against the B6 genetic background. We determined the chromosomal localization of the two loci simultaneously by a one-step mapping process. The chemically induced mutation was identified within the immunoglobulin joining chain (IgJ) gene on chromosome 5. The major serum IgA modifier between the C3H and B6 was located on chromosome 12. This modifier region was mapped to a 350 kb region containing several immunoglobulin heavy-chain genes and the Iga germline switch gene. We speculate that by interfering with both IgA expression and distribution, synergistic regulation of IgA is achieved.
Introduction
Immunoglobulin A (IgA) constitutes only 10-15% of the serum immunoglobulins, but it is the predominant antibody class in external secretions, such as breast milk, saliva, tears and mucus of the bronchial, genitourinary, and digestive tract. In serum, IgA exists primarily as a monomer. In contrast, secretions mainly contain the socalled secretory IgA (sIgA), which is mostly dimeric and contains the immunoglobulin joining chain (J-chain) as well as the secretory component. Dimeric IgA is actively transported through the mucosal epithelium by the polymeric Ig receptor (pIgR), which binds dimeric IgA at the basolateral membrane of epithelial cells and releases IgA at the apical membrane into secretions. The secretory component (SC) is that part of the pIgR which remains covalently bound to the IgA dimer after transcytosis. In rodents, but not in humans, pIgR is also expressed in the liver and mediates clearing of IgA from the circulation and excretion into bile. 1 The J-chain is linked to either pentameric IgM or dimeric IgA molecules. 2 Whereas J-chain incorporation is an early event in dimeric IgA-assembly, this happens relatively late during the assembly of IgM pentamers. 3 J-chain knockout mice with either homozygous or heterozygous deletion of the J-chain exhibit elevated IgA serum levels. 4 In contrast to wild-type mice, mucosal and glandular secretions of J-chain knockout mice contain monomeric IgA, which is not bound to the secretory component. Therefore, the lack of the J-chain does not inhibit a transport of IgA into mucosal secretions, but appears to be required for the covalent linkage to the SC. In contrast, the J-chain is required for hepatic transport of IgA, as IgA levels in bile and faeces are reduced in IgJÀ/À mice, 5 explaining the elevated serum levels. Immature B lymphocytes leaving the bone marrow express immunoglobulin isotypes IgM and IgD on the cell surface and, after maturation, initially produce and secrete IgM upon primary activation. Depending on the cytokine milieu provided by T-helper lymphocytes and the activation status, they may switch to the production of different antibody isotypes, IgG, IgA or IgE, with the same antigen specificity. This somatic recombination process is called isotype switching or class switching. 6 Replacing the C m -C d gene complex with one of the downstream C H genes causes the switching from IgM/ IgD expression to a different isotype. The mechanism of class switch recombination (CSR) is not fully elucidated. CSR is directed by germline transcription. Germline transcripts start from the promoter upstream of an I exon run through the S region and undergo polyadenylation downstream of the C H exon. RNA splicing generates a processed germline transcript by fusing the I exon to the C H exon and deleting the intervening S-region-derived sequences. C H germline transcripts are not translated even though transcription takes place in the cytoplasm. 7, 8 Mutations that abolish germline transcription of the C H genes, for example disruption of the promoter, severely affect class switch recombination. 9 There is also evidence that processing of the germline transcript is required for efficient CSR. 10 In the case of IgA, conflicting data have been generated. On one hand, it has been shown that Ia exon-deficient mice were able to perform proper CSR.
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More recent data revealed that transcription is quantitatively associated with class switch efficiency. 12 In this study, we describe two genetic loci that synergistically create abnormal high serum IgA-levels. We identified a chemically induced mutation in exon 3 of the IgJ gene on chromosome 5 and mapped the major modifier of serum IgA to a 350 kb region on chromosome 12 harbouring the Ig germline Ia exon.
Results
Identification of Mat1, a mutant mouse line with abnormal high IgA serum levels Male C3HeB/FeJ (C3H) mice were mutagenized with ethyl-nitrosurea (ENU) and crossed to untreated C3H females. G1 offspring were analysed for altered regulation of key immunological parameters. Three animals in a litter of six animals showed a 11-fold increased level of serum IgA (2017 mg/ml) compared to C3H wild-type and littermates (189 mg/ml) at day 134, whereas serum IgM and IgG levels were not affected (data not shown). In order to investigate if the ENU induced mutation (termed the Mat1 locus) is strain-specific, we outcrossed the Mat1 locus into the C57BL/6J (B6) background. B6 mice were chosen as they have a significantly (Po0.05) lower serum IgA level (42725 mg/ml) than C3H mice (190775 mg/ml), suggesting the presence of IgA modifier(s) between the two strains that might affect the Mat1 locus.
The resulting F1 OC (G1 Â B6) animals were analysed at day 134 and could be clustered into two distinct populations based on serum IgA levels ( Figure 1a ) that were either higher than 800 mg/ml or lower than 400 mg/ ml. , as their IgA serum levels were above 600 mg/ml. The allele frequency of 86 equally distributed single-nucleotide polymorphisms (SNPs) was determined using pooled DNA of the unaffected group. We observed a significant increase in homozygosity of B6 alleles at two loci, one on chromosome 5, the other on chromosome 12. In contrast and confirming the results, both loci were significantly heterozygous for C3H using pooled DNA from the affected F2 BC animals. Regression analysis (see Materials and methods) determined that the locus on chromosome 12 contributed to 71% of the phenotype variation, whereas chromosome 5 contributed to 39% of the variance. Both loci in combination account for 91% of the serum IgA variation of Mat1 F2 BC animals. In order to differentiate the origin of the two loci, we backcrossed a wild-type C3H/B6 intercross to B6 to derive F2 BC animals that are devoid of the Mat1 mutation. As shown in Figure 1g and h, two groups with high and low IgA serum levels could be distinguished correlating with either C3H-or B6 background (see figure legend). We determined that C3H alleles at the chromosome 12 locus accounted for 90% of the 10-fold increase (compared to wild-type B6) in serum IgA level observed in the B6 background. Consequently, we concluded that in Mat1 F2 BC chromosome 5 (see above) harbours the Mat1 mutation. OC animals (a) were determined at day 134 pp as described in Materials and methods. (a) Two significantly (Po0.05) different groups characterized by high (16837576 mg/ml) and low serum IgA levels (173757 mg/ml) were identified. (b) Serum IgA level distribution of all Mat1 F2 BC animals. The subpopulations used for the one step chromosomal mapping process are discriminated by arrows (unaffected: downward arrow; affected: upward arrow). (c-f) Stratification by IgJ genotypes and heterozygosity for C3H on chromosome 12 creates four distinct subpopulations. Differences in serum IgA levels between populations C and D as well as differences between populations E and F were significant (Po0.05). (g, h) Two significantly (Po0.05) distinct groups of wild-type F2 BC animals were identified. Regulation of serum IgA levels based on the heterozygosity for C3H on chromosome 12. The serum IgA levels of group G (3497159 mg/ ml) correspond with those of the C3H wild-type background (190775 mg/ml), whereas IgA levels of group H (3679 mg/ml) are similar to the B6 wild-type levels (42725 mg/ml). Horizontal bars represent the mean value of the respective subpopulation.
Genetic mapping and identification of a mutation on chromosome 5 in IgJ
The candidate region on chromosome 5 was narrowed using a set of informative markers to a size of approximately 3 cM between markers D5Mit135 and D5Mit205. Mutation analysis of genes located in this region identified a nonsense mutation in the J-chain (IgJ, Refseq NM_152839). The ENU-induced C to A transition at nucleotide 282 of exon 3 creates a premature stop codon at amino-acid position 86 (Tyr86Stop). The identified IgJ point mutation (C282A) was absent in the parental C3H strain as well as in all inbred strains like B6, AKR/N, BALB/c, DBA/2J, 129/svJ, FVB/NJ, MRL/ MpJ and NZB/BINJ analysed. Furthermore, as the premature stop codon cosegregated with the Mat1 phenotype in all animals tested, it is most likely causative for the Mat1 phenotype in C3H.
Stratification by IgJ genotypes resolves the continuous phenotype distribution, synergistic interaction of two dominantly acting loci Using the discovered point mutation as a genetic marker, we stratified the (Figure 1d and f) at chromosome 12, which carries the major modifier locus (see above). Both genetic loci, that is, Mat1 on chromosome 5 and the modifier on chromosome 12 have a dominantly acting and synergistic effect in elevating IgA serum levels in B6 animals. Both loci independently increase serum IgA levels approx. two-and four-fold over wild-type baseline levels. Interestingly, both loci together increase serum IgA levels approximately 40-fold. In this case, the Mat1 locus is responsible for an 11-fold increase in serum IgA levels compared to C3H wild-type levels. Considering that C3H wild-type levels are about four-fold higher than B6 baseline levels, this results in a 40-fold increase in total. In the absence of the dominantly acting C3H modifier, the effect of the Mat1 locus was strongly suppressed in B6 background, which is in line with the modifiers' calculated stronger impact on the phenotype variation (see above).
Genetic mapping of the modifier locus
Owing to the observed strong effects of the C3H modifier locus on chromosome 12 on both the strain difference between B6 and C3H as well as on the Mat1 locus, we decided to refine the mapping position using additional polymorphic markers. Owing to the Mat1-based stratification (Figure 1c-f) , every recombination event on chromosome 12 could be used for fine mapping, which is essentially impossible in a conventional quantitative trait loci (QTLs) analysis (Figure 2) .
We determined the size of the genomic segment harbouring the modifier candidate region with approximately 0.35 Mb, located between markers SNPb-3-4 and D12Mit8 (Figures 2 and 3 ). This candidate region corresponds to bases 107 355 275-107 698 600 of the Ensemble Mouse Feb 2002 Freeze of the mouse genome assembly (http://www.ensembl.org/Mus_musculus/). A total of 12 genes are assigned to or predicted within this region (Figure 3) . Of these 12 genes, we sequenced the Ig germline a-chain I exon (ENSMUSG00000037448, NM_020523). Within the coding sequence and 3000 bp upstream of the ATG-start codon, we identified more than 40 SNPs and several genomic deletions between C3H and B6. Two of these SNPs could be associated with a regulatory motive, both are found in a putative E47/ E12-binding site, 13 which is located 1617 bp upstream the Ig germline a-chain I exon start ATG. This binding site is predicted to be of functional significance for the C57BL/6J strain (GCAGACAGCTGCAGC), but due to the identified SNPs, not for C3HeB/FeJ (GCAGACACTTGCAGC). In addition, we detected a 1-bp deletion (G20 of NM_ 020523) at the beginning of the Ig germline a-chain I region. We deposited the complete C3H sequence in GenBank where it is accessible under SeqID AY520917.
Discussion
Regulation of IgA was found to be critically dependent on two synergistically acting and genetically unlinked genetic loci in mice. The synergistic activity that emanates from the two loci that were located to chromosome 5 and 12 postulates a regulatory, yet undetermined, link between the two sites. The locus on chromosome 12 appears to be mainly responsible for the low serum IgA levels in B6 when compared to C3H mice. In contrast, the locus on chromosome 5 was identified through a chemically induced mutation in C3H.
While positional cloning of monogenetic disorders recently has been very productive, identification of even the major players in complex genetic diseases in humans is still lagging behind. Despite the common notion that identification of causative genes responsible for QTLs in experimental species is extremely laborious, the harvest of these genes is gearing up.
14 The genetic variability between different inbred mouse strains provides phenotypes of medical relevance. The strong QTLs often display a nearly monogenetic character. The chromosomal localization of the locus of interest can be narrowed down, with minimal effort, with a low number of meiotic events (less than 90, this study) and a few hundred genotypings, to a handful of candidate genes for further functional analysis. The phenotype may appear as a complex trait, but is created in fact just by a few major players; stratification by genotypes can break up the continuous phenotype into discrete classes that are then suitable for positional cloning. We have created such a continuous phenotype by crossing the Mat1 locus from a C3HeB/FeJ genetic background into the C57BL/6J background and resolved the QTL-like phenotype into discrete classes where 90% of variance is contributed by just two unlinked loci.
IgA is the predominant antibody class at mucosal surfaces that constitutes the first line of defence against microbial invasion of the body. 4 While serum IgA is mostly monomeric, secretory surfaces provide a greater proportion of polymeric IgA. 15 Secretion is predominantly mediated via the J-chain associated with polymeric IgA (and IgM) binding to the pIgR. 4 However, the J-chain is not absolutely required for IgA transportation to mucosal sites. 5 The function of the J-chain has been intensively addressed by two J-chain KO mouse models, which have led to controversial results and interpretation. 4, 5, 16 Hendrickson et al 5 targeted exon 2, whereas Lycke et al 4 targeted exon 1 of the J-chain gene. Both approaches led to a failure to detect J-chain gene transcripts.
Here, we identified an ENU-induced nonsense mutation at the end of exon 3 of IgJ, which leads to a truncated IgJ protein. The serum IgA phenotype of Mat1 mice generally resembles the described IgJ knockout mice, 4,16 a strong indication that the ENU-induced mutation is responsible for the observed phenotype and that the truncated Mat1 IgJ protein is not functional. The dramatic effects seen in Mat1 heterozygotes compared to the relatively moderate serum IgA elevation in IgJ þ /À mice found by Lycke et al 4 might be explained by transdominat-negative effects of the truncated Mat1 protein.
In line with our results, Hendrickson et al 5 report a more than 20-fold serum IgA elevation in IgJÀ/À mice and no significant differences in serum IgM levels. 16 The observed lack of serum IgM elevation might result out of the fact that J-chain incorporation is an early event in dimeric IgA assembly, whereas this happens relatively late during the assembly of IgM pentamers. 3 However, there exist conflicting results regarding IgA and IgM expression of a published knockout mouse model by Lycke et al. They describe just a two-fold (heterozygous) and four-fold (homozygous) increase in serum IgA levels and dramatically reduced serum IgM levels both in IgJ þ /À and IgJÀ/À mice, respectively. 4 It has been speculated that conflicting results could be due to a different genetic 129J substrain background. 4, 17 Here, we provide evidence that a strain-specific modifier has a dramatic effect on the IgA phenotype.
We were able to reduce the QTL candidate region for the modifier locus on chromosome 12 to 12 annotated genes. The most obvious candidate is the Ig germline achain gene C-switch region. Several proteins and protein complexes have been identified that bind to different immunoglobulin germline switches. We sequenced 3000 bp upstream of the start codon of the Ia exon. Two out of over 40 identified polymorphisms between C3H and B6 could be located within a regulatory region, a potential E47/E12-binding site upstream the Ig germline a-chain Ia exon. It has been shown that activated mature B cells in which the DNA-binding activity of E-proteins has been disrupted fail to undergo CSR. 13 We assume that the strain difference between C3H and B6 in serum IgA levels could be dependent and therefore be explained by the ability of this region to bind regulatory 
Mapping of serum
Regarding the sequence-based predictions of the potential E47/E12-binding site, the effect of the described polymorphism seems more likely to reduce Ig germline a-chain I exon transcription in mouse strain C3H. Site-directed mutagenesis would be required to prove any influence of the described mutations on class switching efficiency. In addition, gel-shift assays could be used to investigate putative differences in the binding capacities of the genomic region. Polymorphisms in the promoter of Ia exon and the Ia exon itself might influence germline transcription or processing of germline transcripts leading to altered IgA expression in Mat1 mice. This is in line with data showing that the efficiency of germline transcription is linearly related to CSR efficiency. 12 However, the candidate region on chromosome 12 also contains genes encoding cysteine-rich intestinal protein 1 (CRIP 1) and CRIP 2. CRIP is highly expressed in immune cells and intestine. 18 Experiments in transgenic mice overexpressing CRIP demonstrated a regulatory function for CRIP particularly in immune cells. 19, 20 Even though CRIP has been shown to influence immune function mainly by the T-cell compartment and the monocyte/macrophage lineage, a regulatory role in Bcell differentiation cannot be excluded.
With the presented mouse-line Mat1, we could show that unravelling of complex phenotypes is feasible and fast. With a single mapping process and stratification of genotypes, we identified two loci that are involved in IgA expression in an additive fashion: the immunoglobulin J-chain gene IgJ on chromosome 5 and a so far unknown QTL on chromosome 12. This model may help us to understand controversial data of different J-chain knockout models and it gives us the possibility to get new insights into heavy-chain class switching to IgA. It further illustrates how production of a gene product (modifier locus, chromosome 12) and its bodily distribution (Mat1, chromosome 5) lead to a strong synergistic phenotypic effect, in this case a 40-fold increase in serum IgA levels.
Materials and methods
ENU treatment and breeding ENU treatment was carried out, as previously described. 21 Briefly, C3HeB/FeJ male mice (The Jackson Laboratory, Bar Harbor ME, USA) were injected intraperitonally three times in weekly intervals between 8 and 10 weeks of age with ENU (Serva Electrophoresis GmbH, Heidelberg, Germany) at a concentration of 85 mg/kg body weight. After recovery, ENU-treated males were mated with untreated C3HeB/FeJ females. G1-offspring mice were screened for serum immunoglobulin levels. Phenotypically affected G1 males were mated with wildtype C3HeB/FeJ females to confirm the genetic basis for phenotype in the G2 generation. One affected animal from the resulting F2 generation was used as the founder of the mutant outcross line. 
Measurement of serum IgA levels

Chromosomal mapping
For chromosomal mapping of the Mat1 locus, a heterozygous C3HeB/FeJ-Mat1/þ G1 individual (designated G0 with respect to the Mat1 line) was outcrossed into a C57BL/6J þ/þ genetic background. Affected F1 OC hybrids were backcrossed to C57BL/6J þ/þ . Affected and unaffected F2 BC individuals were identified and grouped based on high and low serum IgA levels, respectively. For an initial mapping, F2 BC individuals were used. Similar DNA amounts of 21 unaffected individuals were pooled and 86 SNPs equally distributed over the genome were amplified and subjected to genotyping on a Luc96 (Pyrosequencing AB, Sweden) pyrosequencer according to the manufacturer's instructions association to chromosomes 5 and 12 was determined by base-callings identical to inbred C3H. Association results were confirmed in a second reverse experiment using 24 affected individuals. To evaluate the contribution of the identified two loci to the phenotype, all Mat1 F2 BC animals were genotyped with additional markers on chromosomes 5 and 12. The IgA values were regressed against marker D5Mit259 on chromosome 5 and D12Mit20 on chromosome 12 using statistics software (see below). High-resolution mapping using the 89 affected and unaffected F2 BC hybrids was carried out by microsatellite analysis with dye-labelled primers and by SNP sequencing.
Genotyping and sequencing
Microsatellite marker and mapping data were obtained from the Mouse Genome Informatics database (http:// www.informatics.jax.org) and the database of the Whitehead Institute for Biomedical Research/MIT Center for Genome Research (http://www-genome.wi.mit.edu/resources.html). PCR products for the genotyping of the IgJ (C282A; NM_152839) mutation were generated from genomic DNA using primers IgJ-5 (5 0 -GCCGTCTA-TAGCCTGAGAAA-3 0 ) and IgJ-6 (5 0 -CAATGCTTA-CACCCCAATGT-3 0 ). Both primers were also used for sequencing the PCR products. In addition to the parental C3HeB/FeJ strain and the outcross strain C57BL/6J, the following inbred strains were screened for the Matl polymorphism: AKR, BALB, CAST/EI, DBA, 129J and NZB.
The entire coding region of Ig germline a-chain I exon and 3000 bp upstream of the ATG start codon were sequenced for C3HeB/FeJ-background and deposited in GenBank SeqID AY520917.
For genotyping of the marker SNPb-3-4 primers, SNPb-3 (5 0 -GCTCTATGGTTGAAGGGACA-3 0 ) and SNP b-4 (5 0 -GCTGGCCAGACTATCAGAAA-3 0 ) were used for PCR and sequencing. The amplified sequence harbours four SNPs (underlined, C57BL/6J/C3HeB/FeJ) and two C3HeB/FeJ insertions shown underlined and in parenthesis: GCTCTATGGTTGAAGGGACACCAGACTCCTGGTTG GGGACAAAGTCACTTCAGTGTCTGCCACACCTTGA CTTCATTTGGAATTGACTCCCATTTCAAGTTCCTGT GCCTCCTCCCTCCACAGTTTCCAAGCCCTGCTAGTG ACTCTGTCCTTGAGGGATGTCCAGGCTGCCTT(CC)C CCTAACCTTGTCCTGAGTCACTTCTCTCCTTTC/GGT GTCCCCTCAGTATGGATTGTGCTTCCTC(TGGGTCTT CCCTC)AGCCAGGTCTGTCTCCTGTTTCCTCCCACA GAGATCCTGGCCTAGCTAACATCAGTTCCTTGTTCC TCCCTTCCCAGCCTGAGCCTTAGAGAAACTTTCTTT GCAACG/TTAACTTGTCTTCAGCCCG/ACAGTA/G ACACTCATGCTACCTCATAGAATGCAGTAACCTTG GCCTGAGGCGAGAGTTGGAGAAAACTGTCCTAGC AGAAGGTCTTTAGATGGCCAGTTTAGCCACTGTAC AGTACTTTCTGATAGTCTGGCCAGC
Statistical analysis
Values presented in the text are given as average plus/ minus standard deviation (STDV). Regression analysis was performed with the statistical package SPSS 11.5 (SPSS inc., Chicago, USA).
